Moloney Securities Asset Management LLC Sells 731 Shares of Roche Holding AG (OTCMKTS:RHHBY)

Moloney Securities Asset Management LLC trimmed its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 2.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,487 shares of the company’s stock after selling 731 shares during the quarter. Moloney Securities Asset Management LLC’s holdings in Roche were worth $933,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Bard Financial Services Inc. lifted its holdings in Roche by 156.8% during the third quarter. Bard Financial Services Inc. now owns 80,500 shares of the company’s stock valued at $3,216,000 after purchasing an additional 49,150 shares in the last quarter. Verity Asset Management Inc. bought a new stake in Roche in the 3rd quarter valued at $253,000. IHT Wealth Management LLC purchased a new stake in Roche in the 3rd quarter worth $236,000. AlphaMark Advisors LLC bought a new position in shares of Roche during the 3rd quarter valued at about $149,000. Finally, Confluence Investment Management LLC grew its position in shares of Roche by 26.3% during the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock valued at $488,000 after purchasing an additional 2,910 shares in the last quarter.

Wall Street Analyst Weigh In

Separately, Sanford C. Bernstein upgraded Roche to a “strong-buy” rating in a research report on Thursday, January 30th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold”.

Roche Stock Performance

Roche stock opened at $39.77 on Monday. Roche Holding AG has a 52-week low of $29.20 and a 52-week high of $42.43. The firm’s fifty day moving average is $36.62 and its 200 day moving average is $38.31. The company has a quick ratio of 0.97, a current ratio of 1.26 and a debt-to-equity ratio of 0.86.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.